(+)-schisandrin B multiple interactions ISO RGD:1359617 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PXYLP1 mRNA] CTD PMID:31150632 (RS)-amphetamine decreases expression ISO RGD:1359617 6480464 Amphetamine results in decreased expression of ACPL2 mRNA CTD PMID:30779732 17beta-estradiol multiple interactions ISO RGD:1359617 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PXYLP1 mRNA CTD PMID:26496021 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1342803 6480464 Tetrachlorodibenzodioxin results in decreased expression of PXYLP1 mRNA CTD PMID:20106945 , PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1359617 6480464 Tetrachlorodibenzodioxin results in decreased expression of PXYLP1 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PXYLP1 mRNA CTD PMID:21570461 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1342803 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PXYLP1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PXYLP1 mRNA CTD PMID:28628672 3-methylcholanthrene increases expression EXP 6480464 Methylcholanthrene results in increased expression of PXYLP1 mRNA CTD PMID:20713471 4-amino-2,6-dinitrotoluene affects expression ISO RGD:1359617 6480464 4-amino-2, 6-dinitrotoluene affects the expression of PXYLP1 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression EXP 6480464 Fenretinide results in increased expression of PXYLP1 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of PXYLP1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO RGD:1359617 6480464 Propylthiouracil results in decreased expression of ACPL2 mRNA CTD PMID:25825206 8-bromo-3',5'-cyclic AMP decreases expression ISO RGD:1342803 6480464 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PXYLP1 mRNA CTD PMID:22079614 aflatoxin B1 decreases expression ISO RGD:1342803 6480464 Aflatoxin B1 results in decreased expression of PXYLP1 mRNA CTD PMID:27153756 aflatoxin B1 decreases methylation ISO RGD:1342803 6480464 Aflatoxin B1 results in decreased methylation of PXYLP1 gene CTD PMID:27153756 antirheumatic drug increases expression ISO RGD:1342803 6480464 Antirheumatic Agents results in increased expression of ACPL2 mRNA CTD PMID:24449571 azathioprine decreases expression ISO RGD:1342803 6480464 Azathioprine results in decreased expression of PXYLP1 mRNA CTD PMID:22623647 benzo[a]pyrene decreases expression ISO RGD:1342803 6480464 Benzo(a)pyrene results in decreased expression of PXYLP1 mRNA CTD PMID:21632981 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of PXYLP1 mRNA CTD PMID:20713471 benzo[a]pyrene diol epoxide I affects expression ISO RGD:1342803 6480464 7 more ... CTD PMID:20382639 Benzo[k]fluoranthene increases expression EXP 6480464 benzo(k)fluoranthene results in increased expression of ACPL2 mRNA CTD PMID:26377693 bisphenol A multiple interactions ISO RGD:1359617 6480464 [bisphenol A co-treated with Estradiol] results in decreased expression of PXYLP1 mRNA, [bisphenol A co-treated with Testosterone] results in increased expression of PXYLP1 mRNA CTD PMID:26496021 bisphenol A increases methylation ISO RGD:1359617 6480464 bisphenol A results in increased methylation of ACPL2 gene CTD PMID:28505145 bisphenol A multiple interactions ISO RGD:1342803 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PXYLP1 mRNA CTD PMID:28628672 bisphenol A increases expression ISO RGD:1359617 6480464 bisphenol A results in increased expression of ACPL2 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1342803 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PXYLP1 mRNA CTD PMID:28628672 carbamazepine affects expression ISO RGD:1342803 6480464 Carbamazepine affects the expression of ACPL2 mRNA CTD PMID:25979313 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of ACPL2 mRNA, Nanotubes, Carbon results in decreased expression of ACPL2 mRNA CTD PMID:25554681 , PMID:25620056 chloroprene increases expression EXP 6480464 Chloroprene results in increased expression of PXYLP1 mRNA CTD PMID:23125180 copper(II) sulfate decreases expression ISO RGD:1342803 6480464 Copper Sulfate results in decreased expression of PXYLP1 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO RGD:1342803 6480464 Cyclosporine results in decreased expression of ACPL2 mRNA, Cyclosporine results in decreased expression of PXYLP1 mRNA CTD PMID:20106945 more ... dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of PXYLP1 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO RGD:1342803 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PXYLP1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PXYLP1 mRNA CTD PMID:28628672 diazinon increases methylation ISO RGD:1342803 6480464 Diazinon results in increased methylation of ACPL2 gene CTD PMID:22964155 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of PXYLP1 mRNA CTD PMID:21266533 dorsomorphin multiple interactions ISO RGD:1342803 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1342803 6480464 Doxorubicin results in decreased expression of PXYLP1 mRNA CTD PMID:29803840 ethyl methanesulfonate decreases expression ISO RGD:1342803 6480464 Ethyl Methanesulfonate results in decreased expression of PXYLP1 mRNA CTD PMID:23649840 formaldehyde decreases expression ISO RGD:1342803 6480464 Formaldehyde results in decreased expression of PXYLP1 mRNA CTD PMID:23649840 glafenine decreases expression ISO RGD:1359617 6480464 Glafenine results in decreased expression of PXYLP1 mRNA CTD PMID:24136188 indometacin multiple interactions ISO RGD:1342803 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PXYLP1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of PXYLP1 mRNA CTD PMID:28628672 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of PXYLP1 mRNA CTD PMID:21829687 menadione affects expression ISO RGD:1342803 6480464 Vitamin K 3 affects the expression of PXYLP1 mRNA CTD PMID:20044591 methyl methanesulfonate decreases expression ISO RGD:1342803 6480464 Methyl Methanesulfonate results in decreased expression of PXYLP1 mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO RGD:1342803 6480464 methylmercuric chloride results in decreased expression of ACPL2 mRNA CTD PMID:28001369 nickel sulfate decreases expression ISO RGD:1342803 6480464 nickel sulfate results in decreased expression of ACPL2 mRNA CTD PMID:22714537 paracetamol increases expression ISO RGD:1342803 6480464 Acetaminophen results in increased expression of PXYLP1 mRNA CTD PMID:21420995 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of PXYLP1 mRNA CTD PMID:23091169 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of PXYLP1 mRNA CTD PMID:19270015 phenylmercury acetate decreases expression ISO RGD:1342803 6480464 Phenylmercuric Acetate results in decreased expression of ACPL2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1342803 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PXYLP1 mRNA CTD PMID:27188386 pirinixic acid multiple interactions ISO RGD:1342803 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PXYLP1 mRNA CTD PMID:19710929 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of PXYLP1 mRNA CTD PMID:28903501 quercetin decreases expression ISO RGD:1342803 6480464 Quercetin results in decreased expression of PXYLP1 mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO RGD:1342803 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 serpentine asbestos decreases expression ISO RGD:1342803 6480464 Asbestos, Serpentine results in decreased expression of ACPL2 mRNA CTD PMID:21148743 testosterone multiple interactions ISO RGD:1359617 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of PXYLP1 mRNA CTD PMID:26496021 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PXYLP1 mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:1359617 6480464 Carbon Tetrachloride results in decreased expression of PXYLP1 mRNA CTD PMID:31150632 tetrachloromethane multiple interactions ISO RGD:1359617 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PXYLP1 mRNA] CTD PMID:31150632 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of PXYLP1 mRNA CTD PMID:23557971 trichostatin A increases expression ISO RGD:1342803 6480464 trichostatin A results in increased expression of ACPL2 mRNA CTD PMID:24935251 trichostatin A multiple interactions ISO RGD:1342803 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PXYLP1 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO RGD:1342803 6480464 trichostatin A results in decreased expression of ACPL2 mRNA CTD PMID:26272509 urethane decreases expression ISO RGD:1342803 6480464 Urethane results in decreased expression of PXYLP1 mRNA CTD PMID:28818685 valproic acid increases methylation ISO RGD:1342803 6480464 Valproic Acid results in increased methylation of PXYLP1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1342803 6480464 Valproic Acid affects the expression of ACPL2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1342803 6480464 Valproic Acid results in increased expression of ACPL2 mRNA, Valproic Acid results in increased expression of PXYLP1 mRNA CTD PMID:19101580 more ... 
Gene Ontology Annotations
